Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shandong Boan Biotechnology Company., Limited. Class H ( (HK:6955) ) has provided an announcement.
Shandong Boan Biotechnology announced the current composition of its Board of Directors, which includes executive, non-executive, and independent non-executive directors, reflecting a diversified governance structure. The company also detailed the membership and leadership of its five key board committees—Audit, Remuneration, Nomination, Strategy, and Environmental, Social and Governance—clarifying oversight responsibilities and reinforcing its corporate governance framework for investors and other stakeholders.
More about Shandong Boan Biotechnology Company., Limited. Class H
Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company based in the People’s Republic of China and listed in Hong Kong under stock code 6955. The company operates in the biotechnology and pharmaceutical industry, focusing on the research, development, and commercialization of innovative therapies for the healthcare market.
Average Trading Volume: 5,828,037
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.35B
See more insights into 6955 stock on TipRanks’ Stock Analysis page.